A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in En V Veno Medical Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 13,500 shares of NVNO stock, worth $61,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,500
Holding current value
$61,830
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$2.12 - $4.49 $28,620 - $60,615
13,500 New
13,500 $53,000
Q2 2023

Aug 11, 2023

BUY
$2.6 - $5.19 $30,537 - $60,956
11,745 New
11,745 $36,000
Q1 2022

May 13, 2022

SELL
$4.42 - $7.0 $63,206 - $100,100
-14,300 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$6.23 - $10.24 $89,089 - $146,432
14,300 New
14,300 $94,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $43.4M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.